Hemant Kumar Bid
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions
Papers in
-
- Cancer, Hypoxia, and Metabolism 4
- Oncology 13
- Cytokine Signaling Pathways and Interactions 6
- Co-authors
- Rituraj Konwar (18 shared papers)Peter John Houghton (17 shared papers)Rama Devi Mittal (17 shared papers)Parmeet Kaur Manchanda (12 shared papers)Ryan David Roberts (5 shared papers)Kashif Hanif (1 shared paper)Bandana Chakravarti (4 shared papers)Naibedya Chattopadhyay (6 shared papers)
- Journals
- PLoS ONE (5 papers)Molecular Cancer Therapeutics (4 papers)Journal of Endourology (3 papers)Clinical Cancer Research (3 papers)Cancer Research (2 papers)
- Partner nations
- IndiaUnited StatesIsrael
In The Last Decade
Hemant Kumar Bid
69 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 114
- Cancer Research 358
- Oncology 511
- Toxicology 57
- Molecular Biology 1.1k
- Pathology and Forensic Medicine 251
Countries citing papers authored by Hemant Kumar Bid
This map shows the geographic impact of Hemant Kumar Bid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hemant Kumar Bid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hemant Kumar Bid more than expected).
Fields of papers citing papers by Hemant Kumar Bid
This network shows the impact of papers produced by Hemant Kumar Bid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hemant Kumar Bid. The network helps show where Hemant Kumar Bid may publish in the future.
Co-authors
The 25 scholars most cited alongside Hemant Kumar Bid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 217 | |
| 2 | 2012 | 136 | |
| 3 | 2009 | 104 | |
| 4 | 2013 | 103 | |
| 5 | 2010 | 93 | |
| 6 | 2015 | 89 | |
| 7 | 2014 | 79 | |
| 8 | 2016 | 71 | |
| 9 | 2018 | 64 | |
| 10 | 2009 | 58 | |
| 11 | 2014 | 57 | |
| 12 | 2011 | 57 | |
| 13 | Vitamin-D receptor (VDR) gene (Fok-I, Taq-I and Apa-I) polymorphisms in healthy individuals from north Indian population. | 2005 | 56 |
| 14 | 2013 | 52 | |
| 15 | 2009 | 50 | |
| 16 | 2012 | 50 | |
| 17 | 2015 | 49 | |
| 18 | 2013 | 49 | |
| 19 | 2013 | 47 | |
| 20 | 2010 | 46 |
About Hemant Kumar Bid
Hemant Kumar Bid is a scholar working on Cancer Research, Oncology, Immunology, Molecular Biology and Pathology and Forensic Medicine, having authored 69 papers that have together received 2.6k indexed citations. Recurring topics across this work include Kidney Stones and Urolithiasis Treatments (6 papers), Cytokine Signaling Pathways and Interactions (6 papers), Immune Response and Inflammation (5 papers), Protein Degradation and Inhibitors (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Synthesis and biological activity (4 papers), Vitamin D Research Studies (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Cancer Research (358 citations), Oncology (511 citations), Toxicology (57 citations), Molecular Biology (1.1k citations) and Pathology and Forensic Medicine (251 citations). Hemant Kumar Bid has collaborated with scholars based in India, United States and Israel. Frequent co-authors include Rituraj Konwar, Peter John Houghton, Rama Devi Mittal, Parmeet Kaur Manchanda, Ryan David Roberts, Kashif Hanif, Bandana Chakravarti, Naibedya Chattopadhyay, Jiayuh Lin and Shailendra Kumar Dhar Dwivedi. Their work appears in journals such as PLoS ONE, Molecular Cancer Therapeutics, Journal of Endourology, Clinical Cancer Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.